MJardin Group, Inc. ( MJARF) - Stock Earnings
MJARF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 6, 2026, midnight | — / — | — | — / — | — |
MJARF Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021Q1 | -2.4 million USD | 1.0 million USD |
| 2021Q2 | -7.4 million USD | 884689 USD |
| 2021Q3 | -16.8 million USD | 1.0 million USD |
MJARF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2018 | -78268 USD | 2264 USD |
| 2019 | -204.8 million USD | 20.4 million USD |
| 2020 | -27.4 million USD | 9.0 million USD |
| 2026 Est. | — | — |
MJARF
Price: $0
52 week price:
Earnings Per Share: -0.45 USD
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 90140